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Abstract
Background: Nasopharyngeal carcinoma (NPC) is among the most common squamous cell carcinoma in South
China and Southeast Asia. Radiotherapy is the primary treatment for NPC. However, radioresistance acts as a
significant factor that limits the efficacy of radiotherapy for NPC patients. Growing evidence supports that
microRNAs (miRNAs) play an important role in radiation response.
Methods: Real-time quantitative PCR was used to analyze the expression of miR-19b-3p in NPC cell lines and NP69.
miR-19b-3p expression profiles in NPC tissues were obtained from the Gene Expression Omnibus database. The
effect of miR-19b-3p on radiosensitivity was evaluated by cell viability assays, colony formation assays and in vivo
experiment. Apoptosis and cell cycle were examined by flow cytometry. Luciferase reporter assay was used to
assess the target genes of miR-19b-3p. Expression of target proteins and downstream molecules were analyzed by
Western blot.
Results: miR-19b-3p was upregulated in NPC and served as an independent predictor for reduced patient survival.
Radioresponse assays showed that miR-19b-3p overexpression resulted in decreased sensitivity to irradiation,
whereas miR-19b-3p downregulation resulted in increased sensitivity to irradiation in vitro. Moreover, miR-19b-3p
decreased the sensitivity of NPC cells to irradiation in vivo. Luciferase reporter assay confirmed that TNFAIP3 was a
direct target gene of miR-19b-3p. Knockdown of TNFAIP3 reduced sensitivity to irradiation, whereas upregulation of
TNFAIP3 expression reversed the inhibitory effects of miR-19b-3p on NPC cell radiosensitivity. Mechanistically, we
found that miR-19b-3p increased NPC cell radioresistance by activating the TNFAIP3/ NF-κB axis.
Conclusions: miR-19b-3p contributes to the radioresistance of NPC by activating the TNFAIP3/ NF-κB axis. miR-19b-
3p is a determinant of NPC radioresponse and may serve as a potential therapeutic target in NPC treatment.
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Background
Nasopharyngeal carcinoma, which arises from the
nasopharynx epithelium, is a common head and neck
malignancy among the Southeast Asian populations.
Radiotherapy is identified as the primary and only
curative treatment for nasopharyngeal carcinoma [1].
Although advanced radiation technology is available,
the relapse rate of nasopharyngeal carcinoma is as high
as 82%. Radioresistance is a major cause of treatment
failure, leading to incomplete cure, recurrence, and
metastasis [2].
miRNAs are a class of endogenous single-stranded
small noncoding RNA molecules that act as negative
post-transcriptional regulators of target gene expression
[3]. Previous studies indicate that miRNAs directly affect
radioresistance by interfering with specific pathways [4],
including sensing DNA damage [5], repair of DNA
double-strand breaks (DSBs) [6], cell cycle checkpoint
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activation [7], formation of reactive oxygen species [8]
and apoptosis [9], and autophagy [10]. miR-19b-3p
belongs to both the miR-17-92 and miR-106-363 clus-
ters, which play significant roles in proliferation and
cell survival [11, 12]. In particular, miR-19b-3p has
been validated as an oncogene in several human ma-
lignancies [12]. However, the mechanism underlying
the role of miR-19b-3p in NPC radioresistance re-
mains elusive.
Here, we report that miR-19b-3p was upregulated in
NPC tissues and associated with worse patient progno-
sis. In addition, we confirmed that miR-19b-3p could
affect the radiosensitivity of NPC cells by targeting the
3′-UTR of TNFAIP3 and consequently activating the
NF-κB pathway, leading to increased NPC radioresis-
tance in vitro. miR-19b-3p possibly acts as a valuable




miR-19b-3p expression profiles in NPC tissues were ob-
tained from Gene Expression Omnibus (GEO)
(www.ncbi.nlm.nih.gov/geo/). Archived patient samples
in The Cancer Genome Atlas (TCGA) database
(https:// tcga-data.nci.nih.gov and https:// genome-
cancer.ucsc.edu) were selected. Exclusion criteria were
as follows: 1) patients without radiation therapy; and 2)
samples without completed data for analysis. Re-
ceiver operating characteristic (ROC) curve analysis
was performed to determine cutoff score for differ-
entiating between low and high miR-19b-3p levels
among patients [13].
Cell lines and culture conditions
Five NPC cells (CNE1, CNE2, 5-8F, 6-10B and HNE1)
and NP69 were originated from Research Center of
Clinical Oncology of the Affiliated Jiangsu Cancer
Hospital, Nanjing Medical University, Nanjing, China.
The cells were propagated in RPMI 1640 medium
(Hyclone, Logan, UT, USA) containing 10% FBS
(Gibco BRL, Gaithersburg, MD, USA) and 1% anti-
biotic (Gibco BRL), and incubated at 37 °C with CO2
saturated.
Irradiation
Irradiation was delivered at room temperature using a
6 MeV electron beam generated by a linear accelerator
at a dose rate of 400 cGy/min. A compensation glue
with 1.0 cm thickness covered the cell culture con-
tainers. The source-to-skin distance was 100 cm [14].
RNA sample preparation
Total RNA was extracted using TRIzol reagent (Invi-
trogen, Burlington, ON, Canada) according to manu-
facturer’s protocol. RNA yield and purity were
determined by measuring the absorbance (Abs) at 260
and 280 nm. Only RNA samples with Abs260nm/
Abs280nm ratio >1.8 were used.
Cell transfection
CNE-1 and CNE-2 cells were transfected with miR-19b-3p
mimic/inhibitor/TNFAIP3-siRNA (RiboBio Guangzhou,
China) according to manufacturer’s protocol. To determine
the efficiency of miRNA mimic/inhibitor/TNFAIP3-siRNA,
the expression of miR-19b-3p/TNFAIP3 was assessed with
a qRT-PCR detection system (Bio-Rad, Hercules, CA,
USA) and Western blot apparatus.
Quantitative reverse transcription–polymerase chain
reaction analysis
Total RNA was purified using TRIzol reagent (Invitro-
gen, Carlsbad, CA) according to manufacturer’s instruc-
tions. Then, 2 μg of total RNA was reverse-transcribed
using Moloney murine leukemia virus reverse transcript-
ase (Promega, Madison, WI, USA) according to manu-
facturer’s instructions. Expression levels of mature
miRNAs were amplified using SYBR Green quantitative
RT-PCR (qRT-PCR) on an ABI7300 real-time PCR
machine (Applied Bio-systems). The expression of
TNFAIP3 and β-actin was examined using the following
specific primers: 5′-TGTGTATCGGTGCATGGTTTTA-3′
and 5′-TCCTCAGGCTTTGTATTTGAGC-3′ and 5′-G
GACTTCGAGCAAGAGATGG-3′ and 5′-AGCACTGT
GTTGGCGTACAG-3′, respectively. All reactions were
performed in triplicate for each sample. Fold changes for
miR-19b-3p and TNFAIP3 expression levels were calcu-
lated using the 2-ΔΔCt -method.
Cell viability assay
Cell viability was actualized according to literature [15].
Cell counting kit-8 (Beyotime, China) was used accord-
ing to the manufacturer’s instructions to determine the
growth curves for both cell lines. In brief, cells were cul-
tured at 1.5 × 103 cells per well in triplicate in 96-well
plates. Following a 12 h culture, the cells were exposed
to various doses of radiation depending on the aim of
the experiment. Absorbance values were expressed as
percentages relative to the controls.
Colony-forming assay
Clonogenic survival assays were actualized according to
literature [16]. Briefly, cells were plated in 60 mm2 cul-
ture dishes at various cell densities (3 × 102–2 × 103
cells/well) for 12 h and were exposed to ionizing radi-
ation (IR) in doses of 0, 2, 4, 6 and 8 Gy. The cells were
Huang et al. Journal of Experimental & Clinical Cancer Research  (2016) 35:188 Page 2 of 14
cultured for an additional 8–12 days, and colonies were
stained with Giemsa. Surviving colonies (a colony was
defined as >50 cells) were counted. Radiation dose–re-
sponse curves were created by fitting the data to the lin-
ear quadratic equation S = e-αD-βD^2. Area under the
curve (AUC) represents the mean inactivation dose
(MID). The radiation protection factor (RPF) was calcu-
lated by dividing the MID of the test cells by the MID of
control cells.
In vivo experiment
Six week old female nude mice were obtained from
Medical Center of Yangzhou University. (Yangzhou,
China). The nude mice were subcutaneously injected
into the left inguinal with 5 × 106 CNE1 cells respect-
ively. When the xenograft volumes reached 80 mm3, all
mice were divided into 4 groups (n = 6 mice each), in-
cluding miR-19b-3p agomir group (CNE1/miR-19b-3p
agomir group), control agomir group (CNE1/ control
agomir group), combination group 1 (CNE1/ miR-19b-
3p agomir + RT group), combination group 2 (CNE1/
control agomir + RT group). 5 nmol miR-19b-3p agomir
or control agomir (RiboBio) in 50 μl saline buffer was
intratumorally injected into the tumor mass at multiple
sites per mouse, and next day a 5 Gy dose of ionizing ra-
diation was delivered to the combination group 1 and
combination group 2. After 14 days, the combination
group 1 and combination group 2 received another 5 Gy
dose of ionizing radiation. 5 nmol miR-19b-3p agomir or
control agomir (RiboBio) was injected two times a week.
All groups followed for about 4 weeks. Tumor volume
(in mm3) was examined by caliper measurements every
3 to 4 days and calculated by using the modified ellipse
formula (volume = length × width2/2). Nude mice were
sacrificed through decapitation as well as xenograft tu-
mors were rapidly removed after death.
Target prediction for miRNA candidates
Identification of the predicted target mRNA genes of
miRNA provides the basis for understanding miRNA
functions. Thus, candidate target genes of miR-19b-3p
were analyzed using the miRNA target prediction pro-
gram PicTar (http://pictar.mdc-berlin.de/) and miR-
NA.org (http://www.microrna.org/microrna/home.do).
Prediction values were calculated to estimate the bind-
ing affinities of the miRNAs and their predictive target
genes.
Western blot analyses
After 48 h of transfection, cells were extracted and pre-
pared in modified RIPA buffer (Beyotime, Shanghai,
China). Total protein was extracted, and protein concen-
tration was quantified using a BCA protein assay kit
(Beyotime, Shanghai, China). A total of 20 mg of protein
from each sample was used for Western blot analysis.
The primary antibodies used in this study included
monoclonal anti-TNFAIP3 (1:1000; Abcam, HK), anti-
NF-κB/p- NF-κB (1:1000; Cell Signaling Technology,
USA), anti-Bcl-2 (1:1000; Cell Signaling Technology,
USA), anti-Bax (1:1000; Cell Signaling Technology,
USA), and anti-capase-3/c-capase-3 (1:1000; Cell Signal-
ing Technology, USA). β-actin was used as the loading
control. Immunoreactive bands were visualized using
ECL detection reagent (Millipore, Billerica, MA, USA).
All data analyses were repeated thrice independently.
Luciferase reporter construction and luciferase assays
A segment of the human TNFAIP3 3′UTR region con-
taining the predicted binding site for miR-19b-3p based
on the TargetScan database (http://www.targetscan.org)
was synthesized and inserted into the pCDNA3.1 lucifer-
ase reporter vector. The sequence of pri-miR-19b-3p
also was inserted into the pCDNA3.1 plasmid. To gener-
ate the TNFAIP3 3′UTR mutated reporter, a number of
nucleotides in the TNFAIP3 3′UTR that were comple-
mentary to the seed region nucleotides of miR-19b-3p
were mutated. Cells of 293 T line were plated at a dens-
ity of 1.5 × 106 cells in 24-well plates 24 h before trans-
fection. Reporter plasmids and miR-19b-3p expression
plasmids were transfected using the Lipofectamine 2000
reagent (Invitrogen) according to manufacturer’s proto-
col. The cells were lysed 48 h after transfection and their
luciferase activity was assayed using the Picagene Dual
SeaPansy luminescence kit (Toyo Ink, Tokyo, Japan) ac-
cording to standard protocols [12]. All experiments were
performed independently thrice. Luciferase activity was
normalized to total protein concentration.
Flow cytometric analysis of the cell apoptosis in response
to irradiation
After 36 h of transfection, CNE1 and CNE2 cells were
seeded in 6-well plates (5–7 × 105 cells/well and each cell
line had a parallel hole) for 12 h and three parallel holes
were exposed to 6 Gy IR. Cells were harvested after cul-
ture for 3 days and washed twice with ice-cold PBS.
Annexin V–FITC/PI staining was used to detect apop-
totic cells. Three individual experiments were repeated.
Pathway analysis
The candidate target genes of miRNAs were analyzed
using the miRNA target prediction program RNAhybrid
(http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/).
KEGG pathway analyses were performed to identify sig-
nificant signal transduction pathways or enriched meta-
bolic pathways in target gene candidates compared with
the whole reference gene background.
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Statistical analysis
Student’s t-test and one-way ANOVA statistical analyses
were performed with GraphPad Prism 5.0 software and
SPSS 13.0. Data were expressed as mean ± standard devi-
ation from at least three separate experiments. Differ-
ences were considered significant at P < 0.05.
Results
miR-19b-3p is upregulated in NPC and associated with
worse patient prognosis
miR-19b-3p expression profile was obtained using the
GEO database for human nasopharyngeal carcinoma
samples. Specifically, nasopharyngeal carcinoma (n = 62)
expressed significantly more miR-19b-3p than normal
nasopharyngeal samples (n = 6) (GSE36682) (Fig. 1a).
The mRNA level of miR-19b-3p in five NPC cell lines
(CNE1, CNE2, 5-8F, 6-10B, and HNE1) and NP69 were
investigated by qRT-PCR (Fig. 1b). NP69 expressed
lower levels of miR-19b-3p than the five NPC cell lines.
Radiotherapy is identified as the primary treatment for
NPC, but not much information is available on miR-
19b-3p’s function in radioresistance. To further investi-
gate the role of miR-19b-3p in radioresistance, we
analyzed data retrieved directly from TCGA. The cutoff
value of miR-19b-3p was determined by receiver-
operating characteristic analysis, which was used to differ-
entiate between low and high miR-19b-3p levels among
patients (Fig. 1c). Kaplan–Meier survival analysis of pa-
tients was performed based on the expression levels of
miR-19b-3p and revealed that miR-19b-3p level nega-
tively correlated with overall survival of patients
(Fig. 1d). Univariate Cox regression analysis confirmed
that miR-19b-3p expression level and lymph node
classification significantly affected overall survival of
Fig. 1 Expression levels of miR-19b-3p in NPC and correlation of miR-19b-3p expression levels with patient survival. a Expression levels of miR-19b-3p in
normal and NPC tissues. b Expression of miR-19b-3p was upregulated in NPC cells. c ROC analysis was performed to determine the cutoff value of miR-
19b-3p that could differentiate between the NPC patients with low and high miR-19b-3p levels (P< 0.001; area under the ROC curve, 0.658; cutoff value,
6.4751). d Based on the expression levels of miR-19b-3p Kaplan–Meier survival analysis, patients with high miR-19b-3p expression had significantly worse
overall survival than those with low miR-19b-3p expression. The log-rank test was used to calculate p value
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patients. Multivariate Cox regression analysis showed
that high miR-19b-3p expression was an independent
predictor for the reduced overall survival of patients
(Additional files 1 and 2) (Table 1). Taken together,
these data indicate that miR-19b-3p possible play a sig-
nificant role in NPC radioresistance.
Ectopic expression of miR-19b-3p decreases sensitivity to
irradiation
To investigate the potential mechanism behind the role
of miR-19b-3p in NPC radioresistance, we overexpressed
miR-19b-3p in CNE-1 and CNE2 cells by transfected
with miR-19b-3p mimic. QRT-PCR assays revealed that
miR-19b-3p was efficiently upregulated 81.6 ± 2.5 times
in CNE-1 cells and 132 ± 5.29 times in CNE2 (Fig. 2a).
CCK-8 assay demonstrated increased survival rates of
CNE-1 and CNE2 cells with miR-19b-3p overexpression
(Fig. 2b). Moreover, clone survival assay showed that up-
regulation of miR-19b-3p expression markedly decreased
radiosensitivity in the NPC cells [AUC 3.20 (CNE1
mimic) vs. 2.26 (CNE1.NC), RPF = 1.42 AUC 2.86
(CNE2.mimic) vs. 2.51 (CNE2.NC), RPF = 1.14; p < 0.05]
(Fig. 2c, d). The overexpression of miR-19b-3p could sig-
nificantly decrease the sensitivity of NPC cells.
Inhibition of miR-19b-3p increases sensitivity to
irradiation
Following miR-19b-3p overexpression in CNE-1 and
CNE2 cells, we then suppressed miR-19b-3p expression
in CNE1 and CNE2 cells. qRT-PCR confirmed that miR-
19b-3p expression was decreased to 62 ± 0.6% in CNE1/
anti-miR-19b-3p cells and 76 ± 0.85% in CNE2/ anti-
miR-19b-3p (Fig. 3a). CCK-8 assay revealed that the
CNE1 and CNE2 cells with lower miR-19b-3p level had
reduced survival capacity, following irradiation stimula-
tion (Fig. 3b). Furthermore, clone survival assay showed
that downregulation of miR-19b-3p expression in-
creased radiosensitivity in the NPC cells [AUC 2.60
(CNE1.inhibitor) vs. 3.16 (CNE1.NC), RPF = 0.82 AUC
2.92 (CNE2.inhibitor) vs. 3.32 (CNE2.NC), RPF = 0.88;
p < 0.05] (Fig. 3c and d). Taken together, these data
confirm that knockdown of miR-19b-3p could decrease
the resistance of NPC cells to irradiation.
miR-19b-3p decreased the sensitivity of NPC cells to
irradiation in vivo
The in vitro results revealed that overexpression of miR-
19b-3p can influence radiosensitivity in NPC cells, we
furtherly investigated whether miR-19b-3p has a similar
effect in vivo. Nude mice were injected with CNE1 cells.
We found that miR-19b-3p did not affect tumor growth
and weight of group without IR (p = 0.31, p = 0.79), but
could significantly increase tumor growth and weight
compared to that in miR-control group after exposure to
irradiation (p = 0.0011, p = 0.0073) (Fig. 4). These results
are consistent with our in vitro results.
miR-19b-3p depressed apoptosis after irradiation
stimulation
To investigate the potential role of miR-19b-3p in NPC
radiobiology, pathway analysis of miR-19b-3p was per-
formed (Fig. 5a). Results showed that miR-19b-3p may
play a role in several radioresistance-associated path-
ways, such as NF-κB, Wnt, and P53 signaling pathways,
which are closely related to apoptosis and cell cycle.
Thus, both apoptotic and cell cycle effects of miR-19b-
3p were assessed by flow cytometry. We found that
miR-19b-3p overexpression significantly decreased the
percentage of apoptosis in CNE1 and CNE2 cells after
irradiation relative to controls. Conversely, CNE1 and
CNE2 cells with reduced miR-19b-3p significantly in-
creased the percentage of apoptosis (Fig. 5b and c).
However, miR-19b-3p had no effect on the cell cycle of
the NPC cells after irradiation stimulation. The correl-
ation between cell cycle and radioresistance in miR-19b-
3p may be diminished because of cell arrest after irradi-
ation [17] (Fig. 5d).
Table 1 Univariate and multivariate analyses of prognostic
factors for overall survival using Cox proportional hazards
regression model (N =137)
Variable Overall survival
Univariate analysis Multivariate analysis
HR 95% CI HR 95% CI
Gender
Male 1.507 0.617–3.68 1.289 0.515–3.226
Female 1 1
Age (y)
≤61 0.898 0.444–1.819 0.847 0.414–1.732
>61 1 1
Primary tumor (T) stage
T1-T2 0.785 0.368–1.674 0.759 0.351–1.641
T3-T4 1 1
Lymph node (N) classificaction
N0–1 0.418
* 0.205–0.851 0.532 0.252–1.124
N2–3 1 1
Neoplasm histologic grade
G1-G2 0.739 0.348–1.572 0.838 0.382–1.837
G3-G4 1 1
Mir-19b-3p expression level
Low 0.3* 0.104–0.863 0.337* 0.114–0.992
High 1 1
*p < 0.05
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miR-19b-3p regulates TNFAIP3 expression by targeting
the 3′-UTR of TNFAIP3
Identification of the predicted target genes of miRNA
provides the basis for understanding miRNA functions.
Candidate miR-19b-3p target genes were analyzed
using miRNA target prediction websites miRNA.org
(www.microrna.org/microrna/home.do) and PicTar
(http://pictar.mdc-berlin.de/) (Fig. 6a). We identified
TNFAIP3 as a candidate target gene, which includes a
seed sequence at the 3′UTR region that is complementary
to a sequence within the 5′ end of miR-19b-3p. Moreover,
we obtained the expression of miR-19b-3p and TNFAIP3
in 516 head and neck squamous carcinoma tissues from
TCGA. Negative correlation between miR-19b-3p and
TNFAIP3 was also observed (Additional file 3) (Fig. 6b).
In addition, the TNFAIP3 mRNA regions complementary
Fig. 2 miR-19b-3p increased radioresistance of NPC cells. a miR-19b-3p upregulated expression in transfected cells. b Survival rates of different cell
groups were examined using CCK-8 assays in CNE-1 and CNE-2 cells after 2,4,6,8 Gy irradiation. c A clonogenic survival assay shows that transfection of
miR-19b-3p mimic increased NPC cells radioresistance compared with control group after 2,4,6,8 Gy irradiation. d A representative image of colony
formation in CNE-1 and CNE-2 cells exposed to different doses of IR
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to these 6–8 nt seed sequences of miR-19b-3p were highly
conserved among the different species (Fig. 6c).
To further determine whether miR-19b-3p regulates
the translation of TNFAIP3, we transfected CNE1 and
CNE2 cells with miR-19b-3p mimic and NC mimic,
whereas NPC cells were transfected with miR-19b-3p in-
hibitor and NC inhibitor. qRT-PCR showed that the en-
hanced levels of miR-19b-3p significantly decreased
expression of TNFAIP3 mRNA and that downregulated
miR-19b-3p conversely increased expression of
TNFAIP3 mRNA. Western blot analysis revealed that
the protein level of TNFAIP3 was markedly reduced in
the miR-19b-3p-expressing vector compared with the
control vector (Fig. 6d). To further confirm whether the
3′UTR of TNFAIP3 mRNA is a potential functional tar-
get of miR-19b-3p, we generated full length TNFAIP3-3′
UTR luciferase reporter vectors containing a predicted
wild type binding site (TNFAIP3 wt 3′-UTR) or a
Fig. 3 Inhibition of miR-19b-3p increased radiosensitivity of NPC cells. a Downregulated miR-19b-3p expression in transfected cells. b Survival
rates of different cell groups after irradiation were examined using CCK-8 assays after 2,4,6,8 Gy irradiation. c Clonogenic survival assay shows that
transfection of miR-19b-3p inhibitor increased NPC cell radiosensitivity compared with control groupafter 2,4,6,8 Gy irradiation. d Representative
image of colony formation in CNE-1 and CNE-2 cells exposed to different doses of IR
Huang et al. Journal of Experimental & Clinical Cancer Research  (2016) 35:188 Page 7 of 14
mutated version (TNFAIP3 mut 3′-UTR). These vectors
or control pCDNA3.1 vectors were co-transfected with
either the miR-19b-3p or the miR-control vector, and lucif-
erase activity was detected after 48 h. Overexpression of
the miR-19b-3p reduced the luciferase activity of the
TNFAIP3 wt 3′-UTR vector-transfected cells but not that
of the TNFAIP3 mut 3′-UTR vector-or of the control
pCDNA3.1 vector-transfected cells, whereas the control
miR-vector could not significantly change the luciferase
activity (Fig. 6e). These results reveal that miR-19b-3p
could repress TNFAIP3 translation by targeting a specific
3′UTR mRNA binding sequence.
To clarify the mechanism of TNFAIP3 activity in
radioresistance, biological functions of TNFAIP3 were
subjected to KEGG Pathway analyses (Fig. 6f ), which
showed that TNFAIP3 is tightly associated with NF-κB
signaling pathway, which plays an important role in the
regulation of radiosensitivity.
Fig. 4 Overexpression of miR-19b-3p influenced the radiosensitivity of CNE1 cells in vivo. a and b. Representative images of xenograft tumors in
different groups of nude mice with or without irradiation, before (left) or after (right) excision. c Xenograft tumor growth in different groups after
IR. d Quantitative determination of xenograft tumor weight of the excised tumors in different groups at the end of the research. n = 6 for
each groups.*p < 0.05,**p < 0.01
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miR-19b-3p decreases radiosensitivity by targeting
TNFAIP3
To demonstrate the precise functions of TNFAIP3, we
transiently transfected CNE-1 and CNE-2 cells with the
siR-TNFAIP3 or siRNA control. A clone survival assay
showed that knockout of TNFAIP3 markedly decreased
radiosensitivity in the NPC cells [AUC 2.73 (CNE1.siRNA)
vs. 2.35 (CNE1.NC), RPF = 1.17 AUC 2.43 (CNE2.siRNA)
vs. 2.07 (CNE2.NC), RPF = 1.17; p < 0.05] (Fig. 7a and b).
In addition, the survival rate of CNE1 and CNE2 cells with
TNFAIP3 loss was increased after 2,4,6,8 Gy irradiation
stimulation, as detected by CCK-8 assay (Fig. 7c). Knock-
out of TNFAIP3 in CNE1 and CNE2 cells also significantly
decreased the percentage of apoptosis after irradiation
(Fig. 7d). We then performed colony formation assays by
co-transfecting miR-19b-3p inhibitor and siR-TNFAIP3
into NPC cell lines, which showed that decreased expres-
sion of TNFAIP3 restored the significant improvement in
radiosensitivity by downregulating miR-19b-3p expression
[AUC 3.585 (CNE1.inhibitor plus siRNA) vs 2.857
(CNE1.inhibitor plus siRNA.NC), RPF = 1.25 AUC 2.99
(CNE1.inhibitor plus siRNA) vs 2.54 (CNE1.inhibitor plus
siRNA.NC), RPF = 1.18; p < 0.05] (Fig. 7e).
miR-19b-3p increased the activity of NF-κB after irradiation
stimulation
Having determined that miR-19b-3p was able to regulate
NPC radioresistance, its effects on cell apoptosis were
analyzed by transfecting CNE1 and CNE2 cells with
miR-19b-3p mimic or TNFAIP3 siRNA, respectively, be-
fore radiation stimulation. Through bioinformatic ana-
lysis, both TNFAIP3 and miR-19b-3p were found to
have a correlation with the NF-κB pathway. Previous
studies indicate that activated NF-κB plays an important
role in radioresistance [18]. Therefore, we investigated
whether miR-19b-3p mediates NF-κB signaling pathway
by targeting TNFAIP3 and progressively regulated NPC
cell radioresponse. In either TNFAIP3 knockdown or
Fig. 5 miR-19b-3p decreased apoptosis rate after irradiation stimulation. a miRNA-target gene pathway regulatory network was constructed. b
Apoptotic changes in CNE-1 and CNE-2 cells transfected with mimic after exposure to 4 Gy IR for 72 h. Quantification of the percentage of apoptotic
cells (right) is shown. c Apoptotic changes in CNE-1 and CNE-2 cells transfected with inhibitor after exposure to 4 Gy IR for 72 h. Quantification of the
percentage of apoptotic cells (right) is shown. d Alterations in the cell cycle in transfected NPC cells subjected to 4 Gy IR after 72 h. Data are expressed
as mean ± SD of three independent experiments
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transfection of miR-19b-3p mimic, we obtained similar
results after 6 Gy radiation stimulation, as measured by
Western blot (Fig. 8). Specifically, p65 level was de-
creased, and p-p65 level was increased in transfected cell
lines compared with control groups. Because NF-κB is a
known transcription factor of Bcl-2, we sought to
examine the Bcl-2 expression level by Western blot,
which revealed that Bcl-2 level was increased in the
transfected cells. We also detected for Bax and c-
capase3 levels, which both decreased in the transfected
groups compared with the control groups. These stud-
ies show that miR-19b-3p can increase NF-κB activity
by targeting TNFAIP3.
Discussion
With the development of technology, intensity-modulated
radiotherapy (IMRT) has improved locoregional control
and overall survival of NPC compared with crude two-
dimensional radiotherapy techniques and is now the pre-
ferred choice of therapy for NPC [1, 19]. However, NPC
cannot be controlled in about 10% of patients receiving
standard dose of radiation therapy; higher doses of radi-
ation therapy produce severe toxicity [1]. Elucidation of
the regulatory mechanism underlying radioresistance
provides the basis for solving this issue. In the present
study, we found that miR-19b-3p regulates the radiore-
sistance of NPC through the NF-κB signaling pathway
by targeting TNFAIP3 in vitro.
miRNAs, similar to genes, are classified as tumor-
causing (called “oncomiRs”) or tumor-suppressive
(“tumor-suppressive miRNAs”) based on their roles in
cancer [2]. miR-19b has been shown to have a prepon-
derant role in oncogenicity, and is an essential regulator
related to tumor malignant biobehavior. miR-19b can
enhance migration and invasion of lung cancer cells [20]
and is associated with drug tolerance [21]. In cellular
Fig. 6 miR-19b-3p regulated TNFAIP3 expression by targeting the 3′-UTR of TNFAIP3. a Four candidate target genes of miR-19b-3p were predicted
through a miRNA target prediction website. Align score, energy, and context score are all indicated. b A negative correlation was found between
TNFAIP3 and miR-19b-3p in patient tissues. c Sequence alignment of the miR-19b-3p nucleotide sites with the 3′UTR of TNFAIP3 mRNA of different
species. d TNFAIP3 expression and miR-19b-3p overexpression in transfected cells decreased TNFAIP3 protein expression. e The 293 T cells were
transfected with miR-19b-3p or the miR-control vector and were co-transfected with the control luciferase reporter plasmid pmirGLO or with this
reporter plasmid containing the TNFAIP3 wt 3′-UTR or the TNFAIP3 mut 3′-UTR. Luciferase activity was assayed 48 h later. f Biological functions of
TNFAIP3 were subjected to KEGG pathway analyses
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proliferation, however, miR-19b elicits different effects in
different tissues; miR-19b accelerates melanoma cell pro-
liferation, whereas it elicits the opposite effect in hepatic
stellate cell [12, 22]. However, the function of miR-19b-
3p in radioresistance is hardly studied. In the present
study, we found that miR-19b-3p is upregulated in NPC
and is associated with worse patient prognosis. Our data
revealed that miR-19b-3p contributes to radioresistance
in vitro and in vivo. miRNAs exert significant biological
functions by regulating various target genes [23]. Then,
via the miRNA target prediction program, TNFAIP3 is
predicted as a potential target with the highest predictive
value for miR-19b-3p. We further verified that miR-19b-
3p regulates TNFAIP3 expression level by targeting the
3′-UTR of TNFAIP3 mRNA.
TNFAIP3 is widely considered as an important regula-
tor of inflammation and immunity, and plays a key role
in the modulation of immune response to pathogens as
Fig. 7 miR-19b-3p decreased radiosensitivity by targeting TNFAIP3. a Clonogenic survival assay showed that transfection of TNFAIP3 siRNA increased
NPC cell radioresistance compared with control group after 2,4,6,8 Gy irradiation. b Representative image of colony formation in CNE-1 and CNE-2 cells
exposed to different doses of IR. c Survival rates of NPC cells after 2,4,6,8 Gy irradiation were examined by CCK-8 assay. d Apoptotic changes in CNE-1
and CNE-2 cells transfected with si-TNFAIP3 after exposure to 4 Gy IR for 72 h. e Knockdown of TNFAIP3 restored the significant improvement
in radiosensitivity in miR-19b-3p-inhibitor-transfected CNE1 and CNE2 cells after 2,4,6,8 Gy irradiation
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well as the development of inflammatory and auto-
immune disease [24, 25]. Moreover, TNFAIP3 is now ac-
cepted as a disease susceptibility gene that may serve as
a predictive biomarker [26]. However, the potential roles
of TNFAIP3 in regulation of radiosensitivity are rarely
studied. Our data demonstrated that knockout of
TNFAIP3 can decrease NPC cell radiosensitivity. Fur-
thermore, TNFAIP3 knockdown abolished radiosensi-
tization induced by transfection of miR-19b-3p
inhibitor in NPC cells. Overall, miR-19b-3p regulated
nasopharyngeal carcinoma radioresistance by target-
ing TNFAIP3.
Apoptosis is an important mechanism for the regu-
lation of sensitivity to radiation [9, 27]. We found
that overexpression of miR-19b-3p or knockout of
TNFAIP3 decreased apoptosis rates of NPC cell lines
after irradiation. Using bioinformatic analyses, we
found that both miR-19b-3p and TNFAIP3 have a
common apoptotic pathway—the NF-κB signaling
pathway. Ionizing radiation is known to cause DNA
DSBs and leads to lethal injury [9, 28]. IR-induced
DSBs trigger a DNA damage response with NF-κB
activation as the antiapoptotic factor in most cell
types [29–32]. Thus, through the inhibition of NF-
κB activation, radiosensitivity can be increased [33].
Previous studies have demonstrated that TNFAIP3
acts as a repressor that downregulates NF-κB activ-
ity. Indeed, we found that NF-κB activity was en-
hanced after radiation stimulation by the knockout
of TNFAIP3. Furthermore, we confirmed that NF-κB
activity improved after radiation stimulation by over-
expressing miR-19b-3p. To further investigate the
possibility of the mitochondrial signaling pathway as a
molecular pathway for miR-19b-3p, the expressions of
Bcl-2, Bax, capase3, and c-capase3 markers were ex-
amined. Our data revealed similar protein results
from the NPC cell lines after either TNFAIP3 knock-
down or transfection of miR-19b-3p mimic. miR-19b-
3p increased the radioresistance of NPC by increasing
NF-κB activity through TNFAIP3 targeting (Fig. 9).
Fig. 8 miR-19b-3p increased the activity of NF-κB by targeting TNFAIP3. CNE1 and CNE2 cells were transfected with miR-19b-3p mimic or siRNA
against TNFAIP3 before irradiation stimulation. NF-κB, p-NF-κB, Bcl-2, Bax, caspase3, and c-capase3 were detected by Western blot
Fig. 9 miR-19b-3p increased the radioresistance of NPC
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Conclusions
We revealed that miR-19b-3p is upregulated in NPC and
serves as a regulator of NF-κB activity by targeting
TNFAIP3. The newly identified miR-19b-3p/TNFAIP3/
NF-κB axis sheds light on a novel molecular mechanism
for NPC cell radioresistance, indicating that miR-19b-3p
is a valuable biomarker and a promising therapeutic tar-
get for the management of NPC.
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